|
Providing a platform for collaboration and the dissemination of knowledge and information about perinatal stem cells. |
Our Leadership
The non-profit, International Perinatal Stem Cell Society, Inc., was created to provide a platform for collaboration and the dissemination of knowledge and information about perinatal stem cells.
Creating a Society of Cooperation & Partnership
After editing Perinatal Stem Cells (Wiley Press, 2010) and Perinatal Stem Cells, Second Edition (Wiley Press, 2013), the founders of the Perinatal Stem Cell Society wanted to build on the success of these books and to create a robust society of cooperation and partnership that will advance the use of perinatal stem cells from the bench to the bedside. A third book co-edited by society founder, Sean Murphy, and titled Perinatal Stem Cells: Biology and Clinical Applications was published in 2014 (Springer Press). The fourth Perinatal book is due to be release in 2018.
After editing Perinatal Stem Cells (Wiley Press, 2010) and Perinatal Stem Cells, Second Edition (Wiley Press, 2013), the founders of the Perinatal Stem Cell Society wanted to build on the success of these books and to create a robust society of cooperation and partnership that will advance the use of perinatal stem cells from the bench to the bedside. A third book co-edited by society founder, Sean Murphy, and titled Perinatal Stem Cells: Biology and Clinical Applications was published in 2014 (Springer Press). The fourth Perinatal book is due to be release in 2018.
Kyle Cetrulo
President and Founder
kyle.cetrulo@perinatalstemcells.com
Kyle Cetrulo has been interested in Perinatal Stem Cells and non-profit organizations since 1998. As the former Director of the International Cord Blood Society (ICBS), Mr. Cetrulo organized the 5th and 6th International Congresses for the ICBS in 2002 and 2004, which had representatives from 23 countries participate in the meetings.
In 2008, Mr. Cetrulo co-founded Auxocell Laboratories, Inc. (Auxocell). Auxocell achieved profitability in three years under his leadership and Mr. Cetrulo currently remains in the position of Chief Executive Officer at Auxocell. Editor of two editions of Perinatal Stem Cells (Wiley Press, 2010 and 2013) and 2006 guest editor of the Stem Cell Reviews journal special edition focused on Perinatal Stem Cells, Mr. Cetrulo developed relationships with the world’s preeminent stem cell researchers working in the perinatal stem cell field.
In 2013, Mr. Cetrulo along with his co-founders, decided to form the non-profit International Perinatal Stem Cell Society, Inc., in order to provide a platform for collaboration and the dissemination of knowledge and information about perinatal stem cells.
President and Founder
kyle.cetrulo@perinatalstemcells.com
Kyle Cetrulo has been interested in Perinatal Stem Cells and non-profit organizations since 1998. As the former Director of the International Cord Blood Society (ICBS), Mr. Cetrulo organized the 5th and 6th International Congresses for the ICBS in 2002 and 2004, which had representatives from 23 countries participate in the meetings.
In 2008, Mr. Cetrulo co-founded Auxocell Laboratories, Inc. (Auxocell). Auxocell achieved profitability in three years under his leadership and Mr. Cetrulo currently remains in the position of Chief Executive Officer at Auxocell. Editor of two editions of Perinatal Stem Cells (Wiley Press, 2010 and 2013) and 2006 guest editor of the Stem Cell Reviews journal special edition focused on Perinatal Stem Cells, Mr. Cetrulo developed relationships with the world’s preeminent stem cell researchers working in the perinatal stem cell field.
In 2013, Mr. Cetrulo along with his co-founders, decided to form the non-profit International Perinatal Stem Cell Society, Inc., in order to provide a platform for collaboration and the dissemination of knowledge and information about perinatal stem cells.
Rouzbeh R. Taghizadeh, PhD
Director, Secretary, and Founder
rouzbeh.taghizadeh@auxocell.com
Rouzbeh R. Taghizadeh, PhD, has dedicated more than 15 years to bringing stem cell-based therapies to clinical practice. He earned his PhD in Stem Cell Bioengineering in 2006 from the Massachusetts Institute of Technology (MIT).
In 2008, Dr. Taghizadeh co-founded Auxocell Laboratories, Inc. in 2008 and currently serves as Auxocell’s Chief Scientific Officer. At Auxocell, Dr. Taghizadeh developed novel methods and technologies to establish the collection, processing, and banking of stem cells from the human umbilical cord for eventual utilization in stem cell based therapies, regenerative medicine, and other clinical applications. Most notably, Dr. Taghizadeh and his team developed the novel single-use, disposable solid tissue processing system – the patented Auxocell Processing System (AC:Px™).
Dr. Taghizadeh has contributed to numerous peer-reviewed publications, book chapters, and patents and is an editor of the 2nd edition of Perinatal Stem Cells.
Director, Secretary, and Founder
rouzbeh.taghizadeh@auxocell.com
Rouzbeh R. Taghizadeh, PhD, has dedicated more than 15 years to bringing stem cell-based therapies to clinical practice. He earned his PhD in Stem Cell Bioengineering in 2006 from the Massachusetts Institute of Technology (MIT).
In 2008, Dr. Taghizadeh co-founded Auxocell Laboratories, Inc. in 2008 and currently serves as Auxocell’s Chief Scientific Officer. At Auxocell, Dr. Taghizadeh developed novel methods and technologies to establish the collection, processing, and banking of stem cells from the human umbilical cord for eventual utilization in stem cell based therapies, regenerative medicine, and other clinical applications. Most notably, Dr. Taghizadeh and his team developed the novel single-use, disposable solid tissue processing system – the patented Auxocell Processing System (AC:Px™).
Dr. Taghizadeh has contributed to numerous peer-reviewed publications, book chapters, and patents and is an editor of the 2nd edition of Perinatal Stem Cells.
Sean Murphy, PhD
Director, Treasurer, and Founder
semurphy@wakehealth.edu
Dr. Sean V. Murphy received his PhD from Monash University, Melbourne, Australia and is currently a Assistant Professor at the Wake Forest Institute for Regenerative Medicine in North Carolina, USA. His research focuses on the clinical application of perinatal cells and tissues for the treatment of injury and disease. Dr. Murphy has received numerous awards and fellowships, most notably an American Lung Association Senior Research Training Fellowship, and an American Australian Association Sir Keith Murdoch Fellowship.
Dr. Murphy is Director/Secretary and Co-founder of the Perinatal Stem Cell Society, serves on the editorial board of multiple international journals and has recently published the book Perinatal Stem Cells: Biology and Clinical Applications which provides a comprehensive overview of the therapeutic application of perinatal stem cells in both the clinical and preclinical settings.
Director, Treasurer, and Founder
semurphy@wakehealth.edu
Dr. Sean V. Murphy received his PhD from Monash University, Melbourne, Australia and is currently a Assistant Professor at the Wake Forest Institute for Regenerative Medicine in North Carolina, USA. His research focuses on the clinical application of perinatal cells and tissues for the treatment of injury and disease. Dr. Murphy has received numerous awards and fellowships, most notably an American Lung Association Senior Research Training Fellowship, and an American Australian Association Sir Keith Murdoch Fellowship.
Dr. Murphy is Director/Secretary and Co-founder of the Perinatal Stem Cell Society, serves on the editorial board of multiple international journals and has recently published the book Perinatal Stem Cells: Biology and Clinical Applications which provides a comprehensive overview of the therapeutic application of perinatal stem cells in both the clinical and preclinical settings.
Ramon Coronado, MSc, PhD
Dr. Ramon Coronado originated from Venezuela where he completed his B.S. in Polymer Engineering, then relocated to San Antonio, Texas in 2009. He continued his studies through the joint program at UTSA/UTHSCA in Biomedical Engineering, receiving his masters in 2011, followed by his Ph.D. in 2016. In 2013, he founded Mobile Stem Care; a cell-based therapeutic company for animals. Following his success in animal care, Dr. Coronado was named Executive Director of the Lester Smith Medical Research Institute in 2015. There he continues to develop basic, translational, and clinical research programs that apply immune-regulatory mechanisms to improve treatment paradigms. In 2018, he was co-appointed Adjunct Assistant Professor in the Department of Obstetrics and Gynecology at Baylor School of Medicine. Dr. Coronado is currently researching immune-related mechanisms pertinent to fetal-maternal biology, and developing cellular therapies to treat conditions applicable to transplant technologies, immune tolerance, and autoimmune diseases.
Dr. Ramon Coronado originated from Venezuela where he completed his B.S. in Polymer Engineering, then relocated to San Antonio, Texas in 2009. He continued his studies through the joint program at UTSA/UTHSCA in Biomedical Engineering, receiving his masters in 2011, followed by his Ph.D. in 2016. In 2013, he founded Mobile Stem Care; a cell-based therapeutic company for animals. Following his success in animal care, Dr. Coronado was named Executive Director of the Lester Smith Medical Research Institute in 2015. There he continues to develop basic, translational, and clinical research programs that apply immune-regulatory mechanisms to improve treatment paradigms. In 2018, he was co-appointed Adjunct Assistant Professor in the Department of Obstetrics and Gynecology at Baylor School of Medicine. Dr. Coronado is currently researching immune-related mechanisms pertinent to fetal-maternal biology, and developing cellular therapies to treat conditions applicable to transplant technologies, immune tolerance, and autoimmune diseases.
